US FDA calls Wockhardt efforts to fix Wrexham plant 'inadequate'

By Gareth Macdonald contact

- Last updated on GMT

Google maps
Google maps

Related tags: Current good manufacturing, Warning letter, Food and drug administration

Efforts by Wockhardt to fix violations at drug plant in Wrexham, Wales are inadequate according to the US FDA which detailed its concerns in a warning letter this week.

The warning letter​, dated November 16, discusses the Indian drug firm’s response to an inspection last October when agency staff detected a number of violations of current good manufacturing practice (cGMP) at the facility.

The Food and Drug Administration (FDA) said Wockhardt’s response to the inspection – which it received late last year - was ‘inadequate’ and advised it to hire a consultant to help it bring the facility up to code.

Wockhardt acquired the facility in 2003​ when it bought CP Pharmaceuticals.

Just last week the firm said it planned to build a sterile manufacturing and drug testing facility at its site in a $12.4m that will create 50 jobs

The firm did not respond to a request for comment.

Related news

Show more

Related products

How to resolve sticking issues in tablet production

How to resolve sticking issues in tablet production

I Holland Limited - Tabletting Science | 24-Jun-2019 | Case Study

Tablet sticking is one of the most common problems in tablet manufacture. Find out how I Holland used the TSAR scientific predictive model and expert tablet...

How to measure powder and granule flow properties

How to measure powder and granule flow properties

Stable Micro Systems | 01-Apr-2019 | Technical / White Paper

Being able to predict, optimise and control powder flow is of prime importance to manufacturers in ensuring high quality standards. Download this free...

Strategies to Select and Deliver the Right Candidate

Strategies to Select and Deliver the Right Candidate

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

Does your candidate have what it takes to succeed? Do you have the information needed to make the right decisions about your candidate’s path to the clinic?...

Related suppliers

Follow us

Products

View more

Webinars